Cite
Takahashi MD, Chouela EN, Dorantes GL, et al. Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study. Arch Drug Inf. 2010;3(1):1-8doi: 10.1111/j.1753-5174.2009.00025.x.
Takahashi, M. D., Chouela, E. N., Dorantes, G. L., Roselino, A. M., Santamaria, J., Allevato, M. A., Cestari, T., de Aillaud, M. E., Stengel, F. M., & Licu, D. (2010). Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study. Archives of drug information, 3(1), 1-8. https://doi.org/10.1111/j.1753-5174.2009.00025.x
Takahashi, María Denise, et al. "Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study." Archives of drug information vol. 3,1 (2010): 1-8. doi: https://doi.org/10.1111/j.1753-5174.2009.00025.x
Takahashi MD, Chouela EN, Dorantes GL, Roselino AM, Santamaria J, Allevato MA, Cestari T, de Aillaud ME, Stengel FM, Licu D. Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study. Arch Drug Inf. 2010 Mar;3(1):1-8. doi: 10.1111/j.1753-5174.2009.00025.x. PMID: 20428227; PMCID: PMC2855826.
Copy
Download .nbib